SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-15-000014
Filing Date
2015-01-07
Accepted
2015-01-07 17:05:31
Documents
2
Period of Report
2014-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k123114_delmarpharma.htm 8-K 24045
2 FORM OF EXCHANGE AGREEMENT f8k123114ex10i_delmarpharma.htm EX-10.1 64875
  Complete submission text file 0001013762-15-000014.txt   90257
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54801 | Film No.: 15514114
SIC: 2834 Pharmaceutical Preparations